# Filing Detail

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001790340-23-000012
Filing Date
2023-05-01
Accepted
2023-05-01 07:29:36
Documents
3

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEFA14A | immuneeringadditionalproxy.htm | DEFA14A | 12078
2 |  | immuneeringcorporation_vxa.jpg | GRAPHIC | 1104588
3 |  | immuneeringcorporation_vxaa.jpg | GRAPHIC | 1584569
| Complete submission text file | 0001790340-23-000012.txt |  | 3717047

Mailing Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, SECOND FLOOR CAMBRIDGE MA 02142 617-500-8080
Immuneering Corp (Filer) CIK: 0001790340 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-40675 | Film No.: 23870009
SIC: 2834 Pharmaceutical Preparations